MedTrace Logo

Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)

NCT04908839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-02-14

No results posted yet for this study

Summary

Inclusion (J0):

* Audiometry (as part of the treatment, only for cases)
* Clinical evaluation (within the framework of care, only for cases)
* Passage of the French version of the SPOT-25 questionnaire

Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.

Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.

Conditions

  • Otosclerosis

Interventions

OTHER

spot-25 questionnaire

spot-25 questionnaire

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2022-04-06
Completion
2022-04-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04908839 on ClinicalTrials.gov